S-Space

Browse

Subject

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 25 of 25

Issue Date	Title / Author(s) / Citation	File
2003-01	Efficacy of modified regimen with attenuated doses of paclitaxel plus carboplatin combination chemotherapy in elderly and/or weak patients with advanced non-small cell lung cancer Choi, In Sil; Kim, Byung Su; Park, Sook Ryun; Lee, Sang Yoon; Kim, Do Yeun; Kim, Jee Hyun; Lee, Se Hoon; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Lung Cancer, Vol.39 No.1, pp.99-101	DOI
2005-01	Paclitaxel/platinum-based perioperative chemotherapy and surgery in stage IIIA non-small cell lung cancer Choi, In Sil; Oh, Do-Youn; Kwon, Jung Hye; Kim, Sang-Il; Park, Sook Ryun; Bak, Ji-Youn; Kim, Jee Hyun; Kim, Dong-Wan; Kim, Young Tae; Kim, Tae You; You, Chul-Kyu; Kim, Young Whan; Heo, Dae Seog; Bang, Yung-Jue; Sung, Sook Whan; Park, Charn Il; Kim, Noe Kyeong Japanese Journal of Clinical Oncology, Vol.35 No.1, pp.6-12	DOI
2005-07	Efficacy of platinum-based chemotherapy after cranial radiation in patients with brain metastasis from non-small cell lung cancer Kim, Dae-Young; Lee, Keun-Wook; Yun, Tak; Kim, Dong-Wan; Kim, Tae-You; Heo, Dae Seog; Bang, Yung-Jue; Kim, Noe Kyeong Oncology Reports, Vol.14 No.1, pp.207-211	DOI
2008-03	High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer Kim, D-W; Min, H. S.; Lee, K-H; Kim, Y. J.; Oh, D-Y; Jeon, Y. K.; Lee, S. -H.; Im, S. -A.; Chung, D. H.; Kim, Y. T.; Kim, T. -Y.; Bang, Y. -J.; Sung, S. W.; Kim, J. H.; Heo, D. S. British Journal of Cancer, Vol.98 No.6, pp.1118-1124	DOI
2011	The potential for crizotinib in non-small cell lung cancer: A perspective review Bang, Y.-J. Therapeutic Advances in Medical Oncology, Vol.3 No.6, pp.279-291	DOI
2011-02	In vitro and in vivo radiosensitizing effect of valproic acid on fractionated irradiation in U87MG and A549 tumors 지의규	link
2011-04	EGFR Gene Copy Number Gain is Related to High Tumor SUV and Frequent Relapse after Adjuvant Chemotherapy in Resected Lung Adenocarcinoma Koh, Youngil; Jang, Bogun; Jeon, Yoon Kyung; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Chung, Doo Hyun; Kim, Young Tae; Kim, Young Whan; Heo, Dae Seog Japanese Journal of Clinical Oncology, Vol.41 No.4, pp.548-554	DOI
2011-08	Predictive factors for long-term response to pemetrexed treatment in advanced non-squamous, non-small cell lung cancer patients 권지현	link
2013-02	Clinicopathologic significance of SOX2 and FGFR2 expression in non-small cell lung cancer 박혜성	view file
2015-08	Efficacy of AUY922 in lung cancer cell lines with the acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitor 최세훈	view file
2016-03	Pretreatment neutrophil-lymphocyte ratio is not a significant prognostic factor in epidermal growth factor receptor-mutant non-small cell lung cancer patients treated with tyrosine kinase inhibitors Sim, Sung Hoon; Beom, Seung-Hoon; Ahn, Yong-Oon; Keam, Bhumsuk; Kim, Tae Min; Lee, Se-Hoon; Kim, Dong-Wan; Heo, Dae Seog Thoracic Cancer, Vol.7 No.2, pp.161-166	view file DOI
2017-02	A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01) Kim, Hye Ryun; Jang, Joung Soon; Sun, Jong-Mu; Ahn, Myung-Ju; Kim, Dong-Wan; Jung, Inkyung; Lee, Ki Hyeong; Kim, Joo-Hang; Lee, Dae Ho; Kim, Sang-We; Cho, Byoung Chul Oncotarget, Vol.8 No.9, pp.15943-15951	view file DOI
2017-02	Vandetanib in pretreated patients with advanced non-small cell lung cancer-harboring RET rearrangement: a phase II clinical trial Lee, Se-Hoon; Lee, J. -K.; Ahn, M. -J.; Kim, D. -W.; Sun, J. -M.; Keam, B.; Kim, T. M.; Heo, D. S.; Ahn, J. S.; Choi, Y. -L.; Min, H. -S.; Jeon, Y. K.; Park, K. Annals of Oncology, Vol.28 No.2, pp.292-297	DOI
2017-11	PD-L1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study Kim, Hyojin; Kwon, Hyun Jung; Park, Soo Young; Park, Eunhyang; Chung, Jin-Haeng Oncotarget, Vol.8 No.58, pp.98524-98532	DOI
2018-06	Generalization and representativeness of phase III immune checkpoint blockade trials in non-small cell lung cancer Yoo, Shin Hye; Keam, Bhumsuk; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog Thoracic Cancer, Vol.9 No.6, pp.736-744	view file DOI
2019-06	NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors Park, Ha-Ram; Ahn, Yong-Oon; Kim, Tae Min; Kim, Soyeon; Kim, Seulki; Lee, Yu Soo; Kim, Miso; Keam, Bhumsuk; Kim, Dong-Wan; Heo, Dae Seog Cytotherapy, Vol.21 No.6, pp.603-611	DOI
2019-11	The efficacy of immune checkpoint inhibitors in anaplastic lymphoma kinase-positive non-small cell lung cancer Heo, Ja Yoon; Park, Changhee; Keam, Bhumsuk; Ock, Chan-Young; Kim, Miso; Kim, Tae Min; Kim, Dong-Wan; Kim, Se Hyun; Kim, Yu Jung; Lee, Jong Seok; Heo, Dae Seog Thoracic Cancer, Vol.10 No.11, pp.2117-2123	view file DOI
2020-02	Altered expression of fucosylation pathway genes is associated with poor prognosis and tumor metastasis in non-small cell lung cancer Park, Soonbum; Lim, Jin-Muk; Chun, Jung Nyeo; Lee, Sanghoon; Kim, Tae Min; Kim, Dong-Wan; Kim, Sang-Yeob; Bae, Dong-Jun; Bae, Sang-Mun; So, Insuk; Kim, Hong-Gee; Choi, Ji-Yeob; Jeon, Ju-Hong International Journal of Oncology, Vol.56 No.2, pp.559-567	DOI
2020-03	Real-world use of osimertinib in non-small cell lung cancer: ASTRIS study Korean subgroup analysis Cho, Byoung Chul; Kim, Dong-Wan; Park, Keunchil; Lee, Jong-Seok; Yoo, Seung Soo; Kang, Jin Hyoung; Lee, Sung Yong; Kim, Cheol Hyeon; Jang, Seung Hun; Kim, Young-Chul; Yoon, Hyoung-Kyu; Han, Ji-Youn; Kim, Sang-We Current Medical Research and Opinion, Vol.36 No.3, pp.477-482	DOI
2020-12	Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG-LU16-07 Kim, Miso; Keam, Bhumsuk; Ock, Chan-Young; Kim, Se Hyun; Kim, Yu Jung; Lim, Sun Min; Kim, Jin-Soo; Kim, Tae Min; Hong, Sook-Hee; Ahn, Mi Sun; Shin, Seong Hoon; Kang, Eun Joo; Kim, Dong-Wan; Im, Sun-Wha; Kim, Jong-Il; Lee, Jong Seok; Kim, Joo-Hang; Heo, Dae Seog Thoracic Cancer, Vol.11 No.12, pp.3482-3489	DOI
2021-03	Tumor LAG-3 and NY-ESO-1 expression predict durable clinical benefits of immune checkpoint inhibitors in advanced non-small cell lung cancer Jung, Eun Hee; Jang, Hee Ryeong; Kim, Se Hyun; Suh, Koung Jin; Kim, Yu Jung; Lee, Ju-Hyun; Chung, Jin-Haeng; Kim, Miso; Keam, Bhumsuk; Kim, Tae Min; Kim, Dong-Wan; Heo, Dae Seog; Lee, Jong Seok Thoracic Cancer, Vol.12 No.5, pp.619-630	DOI
2021-05	Olmutinib in T790M-positive non-small cell lung cancer after failure of first-line epidermal growth factor receptor-tyrosine kinase inhibitor therapy: A global, phase 2 study Park, Keunchil; Janne, Pasi A.; Kim, Dong-Wan; Han, Ji-Youn; Wu, Ming-Fang; Lee, Jong-Seok; Kang, Jin-Hyoung; Lee, Dae Ho; Cho, Byoung Chul; Yu, Chong-Jen; Pang, Yong Kek; Felip, Enriqueta; Kim, Hyunjin; Baek, Eunhye; Noh, Young Su Cancer, Vol.127 No.9, pp.1407-1416	DOI
2021-08	Plain language summary of the CROWN study comparing lorlatinib with crizotinib for people with untreated non-small cell lung cancer Solomon, Benjamin J.; Bauer, Todd M.; de Marinis, Filippo; Felip, Enriqueta; Goto, Yasushi; Liu, Geoffrey; Mazieres, Julien; Kim, Dong-Wan; Mok, Tony; Polli, Anna; Thurm, Holger; Calella, Anna Maria; Peltz, Gerson; Shaw, Alice T. Future Oncology, Vol.17 No.34, pp.4649-4656	DOI
2024-02	Pralsetinib in patients with RET fusion-positive non-small cell lung cancer: A plain language summary of the ARROW study Griesinger, Frank; Curigliano, Giuseppe; Subbiah, Vivek; Baik, Christina S.; Tan, Daniel S. W.; Lee, Dae H.; Misch, Daniel; Garralda, Elena; Kim, Dong-Wan; van der Wekken, Anthonie J.; Gainor, Justin F.; Paz-Ares, Luis; Liu, Stephen, V; Kalemkerian, Gregory P.; Bowles, Daniel W.; Mansfield, Aaron S.; Lin, Jessica J.; Smoljanovic, Vlatka; Rahman, Ahmadur; Zalutskaya, Alena; Louie-Gao, Melinda; Boral, Andy L.; Mazieres, Julien Future Oncology, Vol.20 No.6, pp.297-306	DOI
	Treatment patterns and results of salvage treatment for regional recurrences after stereotactic ablative radiotherapy for primary non-small cell lung cancer Lee, Choong-Won; Kim, Byoung Hyuck; Wu, Hong-Gyun; Kim, Hak Jae Asia-Pacific Journal of Clinical Oncology	DOI